跳至主要内容
临床试验/CTRI/2025/01/079644
CTRI/2025/01/079644已完成Unknown

A Clinical study to evaluate the 72 Hours Moisturization Potential of Deconstruct multiple skin care Products.

Baypure Lifestyle Pvt Ltd1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2025年2月7日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
32
试验地点
1
主要终点
Change in hydration, TEWL

研究概览

简要总结

Test Product:

1. NMF Oil Free Moisturiser

2. Detan Sunscreen Body Lotion

3. Fluid Brightening Sunscreen

Dose: Gently massage approx. 1 drop of over one block as assigned (forearm) Route of Administration: Topical Duration: 72 hours

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)

入选标准

  • Gender: Male or Female 18 to 40
  • Subjects willing to give written informed consent
  • Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
  • Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
  • Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial).

排除标准

  • Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
  • Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
  • Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
  • Have participated in any interventional clinical trial in the previous 90 days.
  • Have a known sensitivity to any of the constituents of the test product
  • Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
  • Have not skin related issues.

结局指标

主要结局

Change in hydration, TEWL

时间窗: T0min, T+30min, T2hours, T+8hours, T+24hrs, T+ 48hour, T+72hours

次要结局

  • Not Applicable(Not Applicable)

研究者

发起方
Baypure Lifestyle Pvt Ltd
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Robin Chugh

CCFT Laboratories

研究点 (1)

Loading locations...

相似试验